CLOUGH CAPITAL PARTNERS L P

Position in NVO — Novo Nordisk A S

CIK 1276144 Boston, MA

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$17,928,457

+$14,853,873 QoQ

Shares Held

373,977

+867.8% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

1.46%

of 13F equity value

Holder Rank

#105

of 1,348 holders

Holding Since

Dec 2022

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CLOUGH CAPITAL PARTNERS L P holds $44,798,668 across 4 Drug Manufacturers - General names. NVO ranks #2 (40.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	21,081	$25,285,185
2	NVO	Novo Nordisk A S This page	373,977	$17,928,457
3	GILD	Gilead Sciences, Inc.	6,300	$795,942
4	JNJ	Johnson & Johnson	3,107	$789,084

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,928,457	373,977	+1835.7%	Shares	Defined	2026-08-14
2023-03-31	$3,074,584	19,320	+74.1%	Shares	Defined	2023-05-15
2022-12-31	$1,502,274	11,100	—	Shares	Defined	2023-02-14
No filing history on record for this holder in this stock.